Prostate cancer decisions — 2026

The Board has remanded the case due to inadequate consideration of asbestos exposure during service, which may be related to the Veteran's prostate cancer. The AOJ is required to verify any potential asbestos exposure and obtain a VA opinion regarding its etiology.

The Veteran's claims for service connection for coronary artery disease, prostate cancer, and erectile dysfunction have been granted with an effective date of August 2, 2023.,VA received the Veteran's formal claim on August 2, 2023, which was after the January 1, 2020, effective date of the Blue Water Navy Vietnam Veterans Act of 2019. The claims were granted based on presumed exposure to herbicide agents while serving in the Republic of Vietnam.

The Board denied service connection for prostate cancer and arteriosclerotic heart disease (coronary artery disease) and congestive heart failure, finding that the Veteran's current conditions were not related to his military service or toxic exposures. The PACT Act was applied in this case.

The Board has granted service connection for gall bladder and liver infections, as well as prostate cancer, based on the Veteran's exposure to radiation while stationed at Spesutie Island during his military service.

The Board has granted service connection for left and right ankle lateral collateral ligament sprains.,Service connection is also granted for prostate cancer.

The Veteran's claims for an initial compensable rating for service-connected erectile dysfunction and SMC in excess of the current award were denied. The Board found that there was no evidence of renal or voiding dysfunction, which would warrant a compensable rating under Diagnostic Code 7528. Additionally, the Veteran's erectile dysfunction did not meet the criteria for a separate compensable rating under Diagnostic Code 7522 due to the recent amendment of this code. The SMC claim was also denied as there is no provision in law that would allow for an increased rate based on loss of use of a creative organ.

The Board has granted service connection for prostate cancer, finding a current diagnosis and a medical nexus to an in-service exposure to herbicide agents.

The Board is remanding the case to determine if the Veteran was exposed to herbicide agents while on board the USS Kearsarge, which docked or anchored at Sattahip, Thailand. The PACT Act of 2022 extends this presumption for service performed in Thailand.

The Veteran's prostate cancer is granted as service connected due to exposure to contaminated water at Camp Lejeune during his military service.

The Veteran's pilonidal cyst, prostate cancer, bilateral foot skin disorder, left and right foot disorders, sinus disorder, TBI, and migraine headaches are all granted as service-connected.,Service connection is established for the Veteran's pilonidal cyst, prostate cancer (attributable to military service), bilateral foot skin disorder, left and right foot disorders, sinus disorder, TBI, and migraine headaches.

The Board has remanded the cases of prostate cancer, brain cancer, and erectile dysfunction (ED) for further development due to inadequate VA opinions.

The Board has decided that the Veteran's prostate cancer and incontinence as secondary to prostate cancer are not service-connected. The decision is remanded due to a lack of verification regarding the Veteran's participation in any toxic exposure risk activity (TERA) related to his military duties.

The Board has decided to remand the Veteran's claims for service connection due to incomplete development and need for additional examinations. The issues include prostate cancer, bladder bleeding with blood clots, heart disability, diabetes mellitus, neurological impairment of upper extremities, cervical spine disability, right knee disability, and left knee disability.

The Veteran's service-connected disabilities do not render him unable to secure or follow a substantially gainful occupation, as he is capable of performing sedentary employment.

The Board has granted the Veteran's claim for SMC based on aid and attendance, finding that his service-connected disabilities render him in need of regular aid and assistance. However, the Board denied the Veteran's claim for SMC based on housebound status due to the overlap between the conditions that qualify for both benefits.

Service connection is granted for prostate cancer. Service connection is remanded for skin cancer due to a duty-to-assist error.

The Board has remanded the case due to insufficient development regarding potential toxic exposure during service, particularly related to herbicide agents. The Veteran's prostate cancer and its residuals are being evaluated for possible service connection.

The Veteran's prostate cancer was found to have manifested within the one-year presumptive period following his active duty service, meeting the criteria for presumptive service connection.

The Board has restored the Veteran's 40 percent disability rating for service-connected prostate cancer residuals, effective May 1, 2025, as the reduction was improper due to lack of improvement in the Veteran's ability to function under ordinary conditions.

The Veteran's initial rating for diabetes mellitus type II with erectile dysfunction is denied, but he is granted service connection for diabetic peripheral neuropathy of the right and left sciatic nerves as secondary to his service-connected DMII.,The Veteran's prostate cancer residuals are granted an initial 20 percent rating from August 29, 2025.